The first therapy that targets aging is now being tested in humans
Senolytics, the first therapy that targets the aging process directly to delay or prevent diseases related to ageing and is now in human trial, are the first therapies. We thought today was the perfect time to take a closer look at the way they work and who is involved.
Senescent cells, aging and senescent cells
As we age, our cells become more dysfunctional. This is called senescence. These senescent cells no longer divide or support the tissues and organs of which they are part; instead, they secrete a range of harmful inflammatory chemical signals, which are known as the senescence-associated secretory phenotype (SASP).
Source:
https://www.leafscience.org/senolytics-target-aging/
